Erlamide Apalutamide 60mg Sun Pharma

Erlamide Apalutamide 60mg Sun Pharma Specification

Indication
Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC), Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Salt Composition
Apalutamide 60mg

Dosage Form
Tablet

Feature
Androgen receptor inhibitor, oral administration

Ingredients
Apalutamide and excipients

Application
Prescription medication for prostate cancer treatment

Physical Color/Texture
Film-coated tablet

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Usage
Monotherapy or in combination with other therapies for advanced prostate cancer

Packaging Type
Plastic bottle

Packaging Size
120 tablets per bottle

ATC Code
L02BB05

Route of Administration
Oral

Molecule Class
Non-steroidal antiandrogen

Storage Condition
Keep away from children

Strength
60 mg per tablet

Prescription/Non-Prescription
Prescription only (Rx)

About Erlamide Apalutamide 60mg Sun Pharma

Jump on the advanced value offered by Erlamide Apalutamide 60mg from Sun Pharma, a non-steroidal antiandrogen designed with impeccable precision for prostate cancer therapy. Each astonishing bottle contains 120 film-coated tablets of 60mg strength, promising wondrous results as an oral prescription-only treatment. Engineered for both non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer, Erlamide's formulation leverages the proven efficacy of Apalutamide and excipients. To maximize effectiveness and ensure safety, keep away from children, store below 30C, and protect from moisture. Shelf life: 24 months.

Comprehensive Usage and Application

Erlamide Apalutamide 60mg Sun Pharma is specifically indicated for non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. Used as monotherapy or in combination with other therapies, this androgen receptor inhibitor delivers competitive advantages through its targeted oral administration. Its impeccable efficacy and safety profile make it preferred among clinicians, ensuring optimal patient outcomes for those seeking advanced prostate cancer management.

High-Value Packaging and Swift Delivery

Packaged in sturdy plastic bottles containing 120 film-coated tablets, Erlamide Apalutamide 60mg Sun Pharma upholds market value integrity. With stock ready for quick dispatch across India's main domestic market, distributors, dealers, suppliers, and wholesalers benefit from efficient delivery timelines and uncompromised quality. Each bottle is designed for safe storage and convenience, supporting rapid supply and seamless integration into clinical practice.

FAQ's of Erlamide Apalutamide 60mg Sun Pharma:

Q: How should Erlamide Apalutamide 60mg Sun Pharma be stored for optimal efficacy?

A: Erlamide Apalutamide should be stored below 30C, protected from moisture, and kept away from children to maintain its efficacy throughout the 24-month shelf life.

Q: What is the main clinical use of Erlamide Apalutamide 60mg tablets?

A: The tablets are primarily prescribed for treating non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC), either as monotherapy or alongside other treatments.

Q: When can Erlamide Apalutamide 60mg be incorporated into a treatment regimen?

A: Erlamide Apalutamide 60mg is introduced following medical assessment for patients diagnosed with nmCRPC or mCSPC, as determined by a qualified healthcare provider.

Q: Where is Erlamide Apalutamide 60mg Sun Pharma available for purchase?

A: This product is stocked and ready for dispatch throughout India's main domestic market via authorized dealers, distributors, suppliers, wholesalers, and approved pharmacies.

Q: What competitive advantages does Erlamide Apalutamide 60mg provide?

A: Erlamide offers an impeccable safety profile, film-coated oral tablets for ease of administration, rapid market availability, and specialized use in advanced prostate cancer therapy.

Tell us about your requirement